BloggingStocks http://www.bloggingstocks.com BloggingStocks http://www.blogsmithmedia.com/http://www.bloggingstocks.com/media/feedlogo.gif BloggingStocks http://www.bloggingstocks.com en-us Copyright 2012 Weblogs, Inc. The contents of this feed are available for non-commercial use only. Blogsmith http://www.blogsmith.com/<![CDATA[Pfizer (PFE) rises on arthritis drug study]]>http://www.bloggingstocks.com/2009/06/11/pfizer-pfe-rises-on-arthritis-drug-study/http://www.bloggingstocks.com/2009/06/11/pfizer-pfe-rises-on-arthritis-drug-study/http://www.bloggingstocks.com/2009/06/11/pfizer-pfe-rises-on-arthritis-drug-study/#commentsFiled under: , , , ,

PFE logoPfizer (NYSE: PFE - option chain) shares are rising today after the company gave an update on mid-stage studies of its experimental rheumatoid arthritis drug. A Phase Two study shows PFE's oral JAK-3 inhibitor "demonstrates statistically significant response for patients with rheumatoid arthritis." PFE is currently enrolling patients for a phase 3 study of the treatment. If you think that the stock won't fall by too much in the coming months, then now could be a good time to look at a bullish hedged trade on PFE.

PFE opened this morning at $14.09. So far today the stock has hit a low of $14.05 and a high of $14.65. As of 11:45, PFE is trading at $14.60 up 55 cents (3.9%). The chart for PFE looks neutral and S&P gives PFE a neutral 3 STARS (out of 5) hold ranking.

Continue reading Pfizer (PFE) rises on arthritis drug study

Pfizer (PFE) rises on arthritis drug study originally appeared on BloggingStocks on Thu, 11 Jun 2009 13:10:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>arthritisdrug studyDrugStudyinthenewsinvestors observerInvestorsObserveroptionsPFEPfizerThu, 11 Jun 2009 13:10:00 EST